Thyroid, Hashimoto’s, and Peptides: The Gut-Immune Connection for Women
Hashimoto’s thyroiditis is the most common autoimmune condition in the US, and women are affected at 7-10x the rate of men. The relationship between thyroid autoimmunity, gut health, and immune modulation creates a space where peptide research is particularly relevant — though the evidence remains primarily mechanistic.
The Thyroid-Gut-Immune Triangle
Hashimoto’s isn’t just a thyroid problem. It’s an immune system problem that targets the thyroid. The trigger often involves gut permeability ("leaky gut") allowing antigens to cross the intestinal barrier and provoke immune responses that cross-react with thyroid tissue (molecular mimicry). This is why three peptide categories are relevant:
1. Gut-Healing Peptides: BPC-157
If intestinal permeability is a trigger for thyroid autoimmunity, repairing the gut barrier is a logical intervention. BPC-157 protects and repairs gut mucosal lining, potentially addressing one of the upstream triggers of Hashimoto’s. Its anti-inflammatory effects may also help with the chronic low-grade inflammation that accompanies thyroid autoimmunity.
2. Immune-Modulating Peptides: Thymosin Alpha-1
Thymosin Alpha-1 modulates immune function at the T-cell level, shifting the balance between Th1 and Th2 immune responses. Hashimoto’s involves Th1-dominant autoimmunity in many cases. Thymosin Alpha-1’s ability to calibrate immune responses — without suppressing overall immunity — makes it mechanistically interesting. It is approved in 35+ countries for immune modulation.
3. Energy Support: NAD+ and SS-31
Hypothyroidism causes mitochondrial dysfunction — thyroid hormones directly regulate mitochondrial activity. Even with adequate thyroid medication dosing, many Hashimoto’s patients report persistent fatigue. NAD+ and SS-31 (elamipretide) support mitochondrial function through different mechanisms, potentially addressing the cellular energy deficit that thyroid medication alone may not fully resolve.
⚠ Thyroid Medication Interactions: If you take levothyroxine (Synthroid) or other thyroid medications, be aware that GLP-1 agonists (semaglutide, tirzepatide) slow gastric emptying and may affect levothyroxine absorption. Discuss timing adjustments with your endocrinologist. BPC-157 and other non-GLP-1 peptides do not have documented thyroid medication interactions, but always disclose all supplements to your provider.
BioPure Peptides
Code: POWERBPC-157, Thymosin Alpha-1, NAD+, SS-31. Third-party tested.
Shop BPC-157 →Shop Thymosin A-1 →Midwest Peptide
Code: POWER — 10% OffBPC-157 and SS-31 with COAs. Free shipping.
Shop BPC-157 →Shop SS-31 →Frequently Asked Questions
Related Articles
Find Your Peptide Match
Take our 60-second quiz for personalized peptide recommendations based on your goals and life stage.
Take the Quiz →